Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Agents for CNS disorders described by American Home Products

March 10, 1997

Vyrex and Immune Response form collaboration

March 7, 1997

AIT-082 enters clinic

March 7, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

Cypros receives SBIR grant

March 6, 1997

Neuroimmunophilin ligand shows promise for Parkinson's disease

March 6, 1997

Glaxo Wellcome evaluates melatonin agonist

March 6, 1997

Abbott describes AK inhibitor with anticonvulsant/neuroprotective effects

March 6, 1997

Pharmacia & Upjohn claims antimigraine agents

March 6, 1997

RAS inhibitors reduce mortality in a model of cerebral ischemia

March 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...